Lets examine whether this investment makes sense compared to approaches with stronger evidence
For buyers evaluating Peptide Partners, the combination of Finnrick volume and self-published testing provides a stronger verification base than most suppliers
Seeds Office Hours Episode 095 Scott Sherr, MD Jul 2, 2026 Methylene Blue: From Cellular Energy to Clinical Practice Scott Sherr, MD | Luca Gonzlez Forte, PhD Submitted for publication [Article] to the SSRP Institute Abstract Methylene blue (MB) is a century-old compound whose renewed relevance in clinical medicine reflects a clearer understanding of its role in mitochondrial function, redox biology, and neuroinflammatory signaling
Subbiah MT, Yunker R
That's where the conversation turns to peptides, and specifically, to a compound that generates a tremendous amount of interest in research circles: BPC 157
Metabolism Clinical and Experimental Journal 2010;59:1190-1199